Bayer to Present Phase III OCEANIC-STROKE Results
Bayer today announced that the main results from its global, landmark Phase III study OCEANIC-STROKE of asundexian in secondary stroke prevention, will be presented during...
Tag : Bayer
Bayer, Vanderbilt Advance Cardiovascular & Kidney Disease Treatments
Not intended for UK Media Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance...